Top Markets
Coin of the day
Lumos Diagnostics Holdings Limited Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited

LDX
Rang in Aktien #23727
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes... Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Aktienkurs
$0.0740549
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$69.97M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
21.33%
Land
AU
Handel Lumos Diagnostics Holdings Limited (LDX)

Kategorie

Kursverlauf für Lumos Diagnostics Holdings Limited (LDX)
Höchster Schlusskurs: $0.08 am 2026-08-01

Niedrigster Schlusskurs: $0.79 am 2021-07-01
Kursverlauf der Aktie von Lumos Diagnostics Holdings Limited von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -25.09%
2025 654.14%
2024 -46.67%
2023 38.15%
2022 -93.83%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$237.91 -5.54%
IE
$15.36 -18.67%
CN
$526.73 3.88%
CH
$167.77 -8.50%
CH
$2.28 -30.99%
CN